Alife develops artificial intelligence tools to assist physicians in increasing a patient's chances of pregnancy success.
Alife has raised $22.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Alife's investors include Union Square Ventures, Lux Capital, Maveron, Amplo, IA Ventures.
Alife is headquartered in San Francisco, United States.
Alife develops artificial intelligence tools to assist physicians in increasing a patient's chances of pregnancy success.
Alife is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alife — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/alife. Accessed August 13, 2026.
VCBacked. (2022). Alife — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/alife
{{cite web |title=Alife — Funding & Investors |url=https://www.vcbacked.co/company/alife |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated